Predictors of invasion in needle core biopsies of the breast with ductal carcinoma in situ

Modern Pathology

Volumn 23, Issue 5, 2010, Pages 737-742

  Go, Edna May L ^a,b   Chan, Siu Ki ^c   Vong, Joaquim S L ^a   Lui, Philip C W ^a   Chan, Anthony W H ^a   Ma, Tony K F ^d   Ang, Mark A ^b   Law, Bonita K B ^d   Tan, Puay Hoon ^d   Tse, Gary M ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^c KWONG WAH HOSPITAL   (Hong Kong)

^d NORTH DISTRICT HOSPITAL   (Hong Kong)

Author keywords

Breast; Core biopsy; Ductal carcinoma in situ

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER SURGERY; COMEDO; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; NEEDLE BIOPSY; NEEDLE CORE BIOPSY; PRIORITY JOURNAL; TISSUE NECROSIS; TUMOR CALCINOSIS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BREAST; BREAST NEOPLASMS; CALCINOSIS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MIDDLE AGED; NECROSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS;

EID: 77952012369     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2009.187     Document Type: Article

References (32)

1. Parker SH, Burbank F, Jackman RJ, et al. Percutaneous large-core breast biopsy: a multi-institutional study. Radiology 1994;193:359-364.
2. Parker SH, Jobe WE, Dennis MA, et al. US-guided automated large-core breast biopsy. Radiology 1993;187:507-511.
3. Parker SH, Lovin JD, Jobe WE, et al. Stereotactic breast biopsy with a biopsy gun. Radiology 1990;176:741-747.
4. Liberman L, Dershaw DD, Rosen PP, et al. Stereotaxic core biopsy of impalpable spiculated breast masses. AJR Am J Roentgenol 1995;165:551-554.
5. Burbank F. Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions: improved accuracy with directional, vacuum-assisted biopsy. Radiology 1997;202:843-847. (Pubitemid 27093464)
6. Ciatto S, Houssami N, Ambrogetti D, et al. Accuracy and underestimation of malignancy of breast core needle biopsy: the Florence experience of over 4000 consecutive biopsies. Breast Cancer Res Treat 2007;101:291-297.
7. Dillon MF, McDermott EW, Quinn CM, et al. Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only. J Surg Oncol 2006;93:559-563.
8. Wahedna Y, Evans AJ, Pinder SE, et al. Mammographic size of ductal carcinoma in situ does not predict the presence of an invasive focus. Eur J Cancer 2001;37:459-462.
9. Mittendorf EA, Arciero CA, Gutchell V, et al. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Curr Surg 2005;62:253-257.
10. Yen TW, Hunt KK, Ross MI, et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 2005;200:516-526.
11. Mèndez I, Andreu FJ, Sàez E, et al. Ductal carcinoma in situ and atypical ductal hyperplasia of the breast diagnosed at stereotactic core biopsy. Breast J 2001;7:14-18.
12. Renshaw AA. Predicting invasion in the excision specimen from breast core needle biopsy specimens with only ductal carcinoma in situ. Arch Pathol Lab Med 2002;126:39-41.
13. Jackman RJ, Burbank F, Parker SH, et al. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology 2001;218:497-502.
14. Hoorntje LE, Schipper ME, Peeters PH, et al. The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: causes of ductal carcinoma-in-situ underestimates with stereotactic 14-gauge needle biopsy. Ann Surg Oncol 2003;10:748-753.
15. Bonnett M, Wallis T, Rossmann M, et al. Histologic and radiographic analysis of ductal carcinoma in situ diagnosed using stereotactic incisional core breast biopsy. Mod Pathol 2002;15:95-101.
16. Lee CH, Carter D, Philpotts LE, et al. Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted? Radiology 2000;217:466-470.
17. Lagios MD, Westdahl PR, Margolin FR, et al. Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and shortterm treatment failures. Cancer 1982;50:1309-1314.
18. Rutstein LA, Johnson RR, Poller WR, et al. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ. Breast J 2007;13:251-257.
19. Leikola J, Heikkilä P, Pamilo M, et al. Predicting invasion in patients with DCIS in the preoperative percutaneous biopsy. Acta Oncol 2007;46:798-802.
20. Meijnen P, Oldenburg HS, Loo CE, et al. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy. Br J Surg 2007, 94:952-956.
21. Huo L, Sneige N, Hunt KK, et al. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Cancer 2006;107:1760-1768.
22. Lee AH, Hodi Z, Ellis IO, et al. Histological features useful in the distinction of phyllodes tumour and fibroadenoma on needle core biopsy of the breast. Histopathology 2007;51:336-344.
23. Jacobs TW, Chen YY, Guinee Jr DG, et al. Fibroepithelial lesions with cellular stroma on breast core needle biopsy: are there predictors of outcome on surgical excision? Am J Clin Pathol 2005;124:342-354.
24. Lee AH, Hodi Z, Ellis IO, et al. Histological features useful in the distinction of phyllodes tumour and fibroadenoma on needle core biopsy of the breast. Histopathology 2007;51:336-344.
25. Collins LC, Schnitt SJ. Papillary lesions of the breast: selected diagnostic and management issues. Histopathology 2008;52:20-29.
26. Tse GM, Tan PH, Lacambra MD, et al. Papillary lesions of the breast - accuracy of core biopsy. Histopathology (in press).
27. Ely KA, Carter BA, Jensen RA, et al. Core biopsy of the breast with atypical ductal hyperplasia: a probabilistic approach to reporting. Am J Surg Pathol 2001;25:1017-1021.
28. Meyer JE, Smith DN, Lester SC, et al. Large-core needle biopsy of nonpalpable breast lesions. JAMA 1999;281:1638-1641.
29. Houssami N, Ciatto S, Ellis I, et al. Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates. Cancer 2007;109:487-495. (Pubitemid 46190956)
30. Collins LC, Carlo VP, Hwang H, et al. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers. Am J Surg Pathol 2006;30:1002-1007.
31. Hill CB, Yeh IT. Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas. Am J Clin Pathol 2005;123:36-44.
32. Hilson JB, Schnitt SJ, Collins LC. Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications. Am J Surg Pathol 2009;33:227-232.